Alzheimer’s Disease & Cognitive Disorders Program

The Alzheimer’s Disease & Cognitive Disorders Program at the Capital Institute for Neurosciences is led by Dr. G. Peter Gliebus, a fellowship trained specialist in cognitive neurology and Alzheimer’s disease. Dr. Gliebus is board certified in neurology with additional certifications in behavioral neurology and neuropsychiatry.

The program provides comprehensive evaluation, diagnosis and treatment of cognitive disorders such as Alzheimer’s disease, frontotemporal dementia, primary progressive aphasia, mild cognitive impairment and other conditions that cause progressive memory loss as well as changes in language and behavior.

Because our team is highly specialized, we can pinpoint and diagnose the cause of memory and thinking problems more definitively. This enables us to implement a comprehensive, customized care plan to address the many medical and behavioral issues that can accompany Alzheimer’s disease and other dementias, including mental health and sleep-related issues. Treatment may include prescribing currently approved memory enhancing medications. Patients might also need other medications to control their mood, other psychiatric symptoms, or regulate sleep. A non-pharmacological approach to these conditions is a very important part of the treatment plan. This includes educating people about the benefits of regular physical and mental exercises, social interactions and other measures which have been shown to be beneficial to  brain health.

As part of our program, patients are medically evaluated initially to determine if something other than a progressive neurologic condition may be causing their cognitive impairment. Patients are then evaluated using comprehensive cognitive testing and neuropsychological evaluation provided at our Institute by experienced neuropsychologists. Additional testing may be performed, as necessary, including imaging studies such as CT scan or MRI, or other diagnostic tests including blood work, lumbar puncture to check spinal fluid, brain wave test (EEG), among others.

As an integral part of our comprehensive Institute for Neurosciences, the program provides a full range of neurology subspecialists as well as neurosurgeons that can immediately be consulted and engaged regardless of the diagnosed cause of memory loss. Patients may experience memory loss or thinking problems as a result of a cognitive disorder like Alzheimer’s or various dementias. Or, a patient may experience cognitive deficits following a stroke, due to Parkinson’s disease, or other conditions that require the collaborative expertise of one of our other neuroscience specialists.

Dementia is a term used to describe the point at which a patient’s ability to function independently is impaired by memory loss or the ability to think clearly. Signs of dementia may include a combination of significant problems with memory, issues associated with clarity of thinking, focus and attentiveness, and reasoning and visual perception. In the majority of cases, dementia is related to Alzheimer’s disease; however, there are multiple other causes and forms of dementia for which the Cognitive Neurology Program can help. The program also provides support and education for families and caregivers of patients with dementia and Alzheimer’s disease. Learn more about some of the conditions we treat.

Among the conditions the Alzheimer’s Disease & Cognitive Disorders Program treats are:

Appointments can be scheduled with Dr. Gliebus by calling 609-537-7300.  

Back to top